CATALYST PHARMACEUTICALS, INC. (CPRX) Insider Trading

CATALYST PHARMACEUTICALS, INC. (CPRX) has 12 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: July 17, 2026.

Filings
12
Purchases
0
$0
Sales
0
$0
Insiders
12

Most active CPRX insiders

MCENANY PATRICK J
Director
0 bought · 0 sold · July 17, 2026
$131.4M
Miller Steve
Chief Op. & Scientific Officer
0 bought · 0 sold · July 17, 2026
$34.5M
DENKHAUS DONALD A
Director
0 bought · 0 sold · July 17, 2026
$15.7M
Tierney David S
Director
0 bought · 0 sold · July 17, 2026
$12.1M
Daly Richard J
President and CEO
0 bought · 0 sold · July 17, 2026
$8.5M
Elsbernd Brian
Chief Legal Officer
0 bought · 0 sold · July 17, 2026
$7.6M
Sundaram Preethi
Chief Strategy Officer
0 bought · 0 sold · July 17, 2026
$1.7M
Del Carmen Jeffrey
Chief Commercial Officer
0 bought · 0 sold · July 17, 2026
$452K

Latest CPRX Form 4 filings

Date Insider Value Shares Stake Pre-planned Links
July 17, 2026 filed July 15, 2026 Russo Gregg Chief HR Officer $14,994 72,262 −100% No
July 17, 2026 filed July 15, 2026 Miller Steve Chief Op. & Scientific Officer $34,454,795 2,565,452 −100% No
July 17, 2026 filed July 15, 2026 Curran Daniel J. Director $0 63,583 No
July 17, 2026 filed July 15, 2026 Thompson Tamar Director $118,850 123,436 −100% No
July 17, 2026 filed July 15, 2026 Tierney David S Director $12,074,391 561,477 −100% No

Showing the 5 most recent of 12 filings in the last 90 days.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.

Get alerted when CPRX insiders trade

Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.

Start free